Peter E. Boyd - 14 Jun 2022 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Reporting relationship: SVP-Bus. Process & Info. Tech.
Issuer ticker: AQST
Reported as of: 14 Jun 2022
Net transaction value: +$4,050
SEC form: 4
Accepted by SEC: 15 Jun 2022, 10:24:07 UTC
Prior SEC filing: 10 Jun 2022
Next SEC filing: 08 Nov 2022
Source filing: View source filing
Reporting owner signature: /s/ Lori J. Braender, as Attorney-in-Fact

Key filing fact

Peter E. Boyd filed Form 4 for Aquestive Therapeutics, Inc. (AQST) on 15 Jun 2022.

Key facts

This page summarizes Peter E. Boyd's Form 4 filing for Aquestive Therapeutics, Inc. (AQST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jun 2022, 10:24.

Change

Previous filing in this sequence was filed on 10 Jun 2022.
Current net transaction value: +$4,050.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AQST transaction

Common Stock

Purchase

Transaction value: $4,050
Shares: +5,000
Change %: +9.2%
Price: $0.8100
Shares after: 59,532
Date: 14 Jun 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple transactions at the price of $0.81. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was effected.